Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Joint Bone Spine|July 15, 2021
The impact of osteoporosis and vertebral compression fractures on mortality and association with pulmonary function in COPD: A meta-analysisLoukas Kakoullis, Fotios Sampsonas, Vasileios Karamouzos, et al.Minerva Endocrinology|October 20, 2021
Effect of spironolactone on pharmacological treatment of nonalcoholic fatty liver diseaseApostolis Papaefthymiou, Michael Doulberis, Kyriaki Karafyllidou, et al.Respiratory Research|December 23, 2021
Tocilizumab improves 28-day survival in hospitalized patients with severe COVID-19: an open label, prospective studyTheodoros Karampitsakos, Elli Malakounidou, Ourania Papaioannou, et al.Cancers|February 13, 2026
Lipidemic Profile of Patients with Non-Small Cell Lung Cancer and Its Association with Driver Mutations: A Tertiary Center Retrospective StudyMaria Lagadinou, Dimitrios Efthymiou, Fotios Sampsonas, et al.Frontiers in Immunology|May 21, 2026
Design of the MERCURION-IPF trial - intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosisVasilina Sotiropoulou, Fotios Sampsonas, Eirini Vasarmidi, et al.Scientific Reports|October 6, 2019
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC PatientsFoteinos-Ioannis D Dimitrakopoulos, Anna G Antonacopoulou, Anastasia E Kottorou, et al.ERJ Open Research|May 5, 2022
Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosisTheodoros Karampitsakos, Ourania Papaioannou, Ilias Dimeas, et al.Respiration; International Review of Thoracic Diseases|September 30, 2021
Safety and Effectiveness of Mycophenolate Mofetil in Interstitial Lung Diseases: Insights from a Machine Learning Radiographic ModelTheodoros Karampitsakos, Christina Kalogeropoulou, Vasilios Tzilas, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 23, 2022
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trialTheodoros Karampitsakos, Ourania Papaioannou, Panagiota Tsiri, et al.Cancers|August 28, 2025
Geographical Inequalities and Comorbidities in the Timely Diagnosis of NSCLC: A Real-Life Retrospective Study from a Tertiary Hospital in Western GreeceFotios Sampsonas, Pinelopi Bosgana, Emmanouil Psarros, et al.Pageof 5